E9 Hydrogen solves the dual challenges of renewable energy curtailment and expensive green hydrogen production. Utilizing proprietary Co-Axial Membraneless technology, E9’s system is purpose-built for intermittent, behind-the-meter operation. By prioritizing robust durability for frequent start-stop cycles over peak efficiency, it eliminates precious metals to achieve a radically low capital cost of $600 to $800 per […]
By CJ Evans, Co-Founder, The Alternative Fuels & Chemicals Coalition (AFCC) Special to The Digest For over two decades, the United States bioeconomy has possessed the technological ingenuity to replace fossil-derived fuels, chemicals, and products, revitalize rural economies, establish domestic energy independence, and challenge global competitors for energy dominance. Yet, a persistent and formidable barrier […]
Biorefinery retrofits, such as converting ethanol plants to sustainable aviation fuel, face a critical financing gap: senior lenders limit brownfield exposure while equity demands prohibitively high returns. Mezzanine debt effectively bridges this divide, providing essential subordinated capital tailored to conversion risks. Because strong brownfield assets mitigate technology risks, they can secure mezzanine pricing 200 to […]
“G’day, Brian.” “Hmmm.” “I’ve brought tea.” “Put it down quietly.” “What were you reading?” “The future.” Only then did I notice where I was. It was one of those crisp Australian winter mornings that persuade you walls are an optional extra. Dr. Brian Westlake’s cabin stood somewhere on the Lachlan River. Or perhaps the Little […]
Following the Inflation Reduction Act, the DOE Loan Programs Office (LPO) transformed into the bioeconomy’s primary sovereign anchor lender. An LPO conditional commitment powerfully crowds in private capital by validating project viability. However, surging application volumes have stretched due-diligence cycles by 30 to 50 percent. Because institutional throughput—not capital availability—is the true bottleneck, sponsors must […]
The era of cheap financing is over, replaced by tighter debt-service requirements and IRR targets elevated by 200 to 400 basis points. Today, capital structure determines project survival more than technology. To remain financeable, bioeconomy developers must design capital-efficient, modular projects and secure patient capital from infrastructure funds. Additionally, integrating policy incentives—like transferable tax credits […]
“Coming this summer from Marvel Studios…” The trailer opens in darkness. A steel vault disappears into the bedrock beneath a mountain. Massive blast doors seal shut. Banks of cryogenic pipes hiss into life. Behind reinforced glass stands the world’s most dangerous man: the Winter Soldier. The world has finally captured him. A powerful international coalition […]
By Cynthia Thyfault, Founder & CEO, QuantaVision I have been working with Section 9003 since it was written into the 2008 Farm Bill — not as a policy observer, but as someone who has sat with developers at the application table, worked alongside lenders trying to underwrite these projects, and watched technologies with real commercial […]
First-of-a-kind (FOAK) bioeconomy plants face a critical 12-to-24-month funding gap between mechanical completion and commercial operations. Construction lenders exit at commissioning, while permanent lenders require verified operating data before underwriting debt. Without revenue, this unfunded “ramp period” threatens project survival. To prevent fatal delays, sponsors must proactively embed bridge financing—using milestone-based draws from private credit […]
Being an account of a curious inquiry into the true nature of renewable octane. The fog had settled heavily over Baker Street, softening the glow of the gas lamps into pale amber halos. The last of the Baker Street Irregulars had departed an hour earlier, their muddy boots and excited chatter leaving behind only silence […]
